The biotech firm, which has filed to uplist on the Nasdaq exchange, said the program will take place at NYU Langone Health
Mind Medicine () Inc (NEO:MMED) () (NEO:MMED) is committing $5 million over five years to establish and launch a program to train the next generation of psychiatrists and clinical investigators in the field of psychedelic assisted therapies and medicines.
The biotech firm, which has filed to uplist on the Nasdaq exchange, said ...
